Chordate Medical Holding AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.651052 million compared to SEK 0.020347 million a year ago. Revenue was SEK 0.67424 million compared to SEK 0.040655 million a year ago. Net loss was SEK 9.84 million compared to SEK 8.08 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.05 a year ago.
For the full year, sales was SEK 1.75 million compared to SEK 0.108517 million a year ago. Revenue was SEK 1.92 million compared to SEK 0.163954 million a year ago. Net loss was SEK 29.19 million compared to SEK 27.94 million a year ago. Basic loss per share from continuing operations was SEK 0.13 compared to SEK 0.18 a year ago.